Lb Pharmaceuticals Inc · NASDAQ:LBRX
TCG Crossover GP II, LLC reported a 6.40% stake in Lb Pharmaceuticals Inc (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
TCG Crossover GP II, LLC reported a 6.40% stake in Lb Pharmaceuticals Inc, 1,839,489 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 1,839,489
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 6.40% | 1,839,489 |
| TCG Crossover Fund II, L.P. | 6.40% | 1,839,489 |
| Chen Yu | 6.40% | 1,839,489 |
Source
Related
- Lb Pharmaceuticals Inc
- TCG Crossover GP II, LLC
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · TCG Crossover GP II, LLC · Sep 18, 2025
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026